Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Firms Must Do More To Make Their NDIs Succeed – Consultant

This article was originally published in The Tan Sheet

Executive Summary

FDA has caused "great concern" by turning down 85 percent of new dietary ingredient submissions in the past three years, but firms commonly set themselves up for rejection, industry consultant Chris Noonan says

You may also be interested in...

NDI Notification Failures Concern FDA; Complete Submissions Urged

Supplement ingredients being sold without undergoing the NDI notification process rank among top concerns for FDA's Center for Food Safety and Applied Nutrition, according to center Director Robert E. Brackett

CFSAN Seeks Recommendations On Fiscal 2008 Priorities

FDA's Center for Food Safety and Applied Nutrition is seeking comments on its fiscal 2008 priorities as it starts the final quarter of a year in which it achieved multiple significant goals

FDA On Lookout For “Shenanigans” In Nutritionals – Consultant

More FDA enforcement action is focusing on regulatory compliance by nutritional supplement firms in part because there is "plenty of room for shenanigans" in marketing the products, according to John Avellanet, a compliance consultant





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts